Skip to results
Modify your search
NARROW
1-6 of 6
Authors: Maxime Ronot
Journal Article
Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma Free
British Journal of Surgery, Volume 109, Issue 5, May 2022, Pages 455–463, https://doi.org/10.1093/bjs/znac017
Published: 10 February 2022
Journal Article
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients’ Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study Free
The Oncologist, Volume 24, Issue 11, November 2019, Pages e1082–e1090, https://doi.org/10.1634/theoncologist.2018-0672
Published: 25 March 2019
Journal Article
EDITOR'S CHOICE
The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort Get access
European Heart Journal, Volume 40, Issue 13, 01 April 2019, Pages 1057–1068, https://doi.org/10.1093/eurheartj/ehy620
Published: 20 October 2018
Journal Article
LBA-001Efficacy, tolerability and impact on quality of life of selective internal radiation therapy (with yttrium-90 resin microspheres) or sorafenib in patients with locally advanced hepatocellular carcinoma: The SARAH trial Get access
Annals of Oncology, Volume 28, Issue suppl_3, June 2017, mdx302, https://doi.org/10.1093/annonc/mdx302
Published: 03 July 2017
Journal Article
Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib Free
The Oncologist, Volume 19, Issue 4, April 2014, Pages 394–402, https://doi.org/10.1634/theoncologist.2013-0114
Published: 20 March 2014
Journal Article
Hepatobiliary and Pancreatic Neoplasms in Patients With McCune-Albright Syndrome Get access
The Journal of Clinical Endocrinology & Metabolism, Volume 99, Issue 1, 1 January 2014, Pages E97–E101, https://doi.org/10.1210/jc.2013-1823
Published: 01 January 2014
